Metformin Corrects Abnormal Circadian Rhythm and Kir4.1 Channels in Diabetes

Abstract

PURPOSE. Diabetic retinopathy (DR) is a leading cause of visual impairment. Müller cells in DR are dysfunctional due to downregulation of the inwardly rectifying potassium channel Kir4.1. Metformin, a commonly used oral antidiabetic drug, is known to elicit its action through 5 adenosine monophosphate-activated protein kinase (AMPK), a cellular metabolic regulator; however, its effect on Kir4.1 channels is unknown. For this study, we hypothesized that metformin treatment would correct circadian rhythm disruption and Kir4.1 channel dysfunction in db/db mice. METHODS. Metformin was given orally to db/db mice. Wheel-running activity, retinal levels of Kir4.1, and AMPK phosphorylation were determined at study termination. In parallel, rat retinal Müller cell line (rMC-1) cells were treated using metformin and 5aminoimidazole-4-carboxamide ribonucleotide (AICAR) to assess the effect of AMPK activation on the Kir4.1 channel. RESULTS. The wheel-running activity of the db/db mice was improved following the metformin treatment. The Kir4.1 level in Müller cells was corrected after metformin treatment. Metformin treatment led to an upregulation of clock regulatory genes such as melanopsin (Opn4) and aralkylamine N-acetyltransferase (Aanat). In rMC-1 cells, AMPK activation via AICAR and metformin resulted in increased Kir4.1 and intermediate core clock component Bmal-1 protein expression. The silencing of Prkaa1 (gene for AMPKα1) led to decreased Kir4.1 and Bmal-1 protein expression. CONCLUSIONS. Our findings demonstrate that metformin corrects abnormal circadian rhythm and Kir4.1 channels in db/db mouse a model of type 2 diabetes. Metformin could represent a critical pharmacological agent for preventing Müller cell dysfunction observed in human DR.

Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma

“…This result would be a clue to understanding the effect of metformin on ER stress. It seems surprising that antidiabetic drug metformin affects circadian rhythm, but some reports indicate the relationship between metformin and circadian rhythm [23, 24]. Both CRY1 and CRY2 were pointed as upstream regulators in this study, and they are known to regulate circadian rhythms.…”

Envisioning the role of inwardly rectifying potassium (Kir) channel in epilepsy

“…Moreover, in diabetic mice, whole‐cell patch‐clamp recordings in hippocampal brain slices showed decreased Kir4.1 currents, resulting in impaired potassium homeostasis and increased excitability (Méndez‐González et al., 2020). Metformin, a widely used antidiabetic drug, was observed to increase Kir4.1 expression (Alex et al, 2020). In this context, metformin may represent a critical target in the treatment of diabetic patients with epileptic seizures.…”

Metformin and Bone Metabolism in Endogenous Glucocorticoid Excess: An Exploratory Study

“…Quality of life and depressive symptomatology revealed no significant differences between the two study groups ( Supplementary Table 1 ). However, metformin showed antidepressant effects in larger cohorts and animal models ( 8 , 32 ), and was even shown to correct abnormal circadian rhythm on a cellular level via an activation of AMPK ( 33 ). Mechanistically, the action of metformin is not yet fully understood.…”